Rezvoglar KwikPen
NDC 0002-8980, Insulin glargine-aglr, injection, solution, from Eli Lilly and Company.
- Product NDC
- 0002-8980
- Status
- Listed
- Labeler
- Eli Lilly and Company
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- BLA
- Application
- BLA761215
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8980 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- INSULIN GLARGINE100 [iU]/mL
Pharmacologic classes
Insulin Analog [EPC]; Insulin [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 0002-8980-05 | 00002898005 | 5 SYRINGE in 1 CARTON (0002-8980-05) / 3 mL in 1 SYRINGE (0002-8980-01) |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/f6af8706-2058-4fe1-99c8-43684c20bfa2NADAC price for package 00002898005
GET /v1/drugs/nadac/00002898005
Use it
Look up 0002-8980 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/0002-8980 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 0002-8980. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.